SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: RT who wrote (6918)4/13/1998 6:40:00 PM
From: Mkilloran  Read Replies (1) of 23519
 
Keep both plants going....just move what is cheaper to the new plant.

The old plant can produce 1.6 mill units a qtr (600,000 * 3 production lines)....assuming the 8 additional production lines at the new plant ramp-up with the same capacity 600,000 units a month...that's only 4.8 mill units a qtr. UK sales in the last 4 1/2 weeks were $1.9 mill dollars @~$7.00 a dose to Astra that's 300,000 units ...1/2 a production line alone. Any estimates as to the size the UK will grow in qtr 2??? How about 600,000 units a month?? Now add Brazil, Argentina, S. Korea, Switzerland. and a growing ED market in the USA. Get a few more countries approved in qtr 2 and 3 and you'll need both plants producing....don't want to be caught short again. How big a market is China? Japan? etc,etc......
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News